A spokesperson for Eli Lilly previously said in a statement: "Retatrutide is an investigational, once-weekly, triple hormone receptor agonist, which activates the body's receptors for glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon
White AT (WAT) in obese tissue has been observed to increase the number of macrophages and mast cells compared to lean tissue leading to increased gene expression of TNF- and a remarkable increase in IL-6 and iNOS levels (25, 28)
Discuss your health goals with a licensed physician and determine if peptide therapy is right for you
For quantitative synthesis, effect estimates were collected when available, including HRs, 95% CI, and associated p-values
An article on Medicinenet.com called " What Does Oxidative Stress Mean